ProfileGDS5822 / ILMN_3161036
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 27% 1% 21% 45% 41% 5% 46% 26% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 114.627
GSM1276600PDAC Late Ablation Control 26.61
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 111.521
GSM1276603PDAC Late Ablation 220.545
GSM1276604PDAC Late Ablation 319.941
GSM1303940PDAC Late Ablation_anti-CTLA4 16.95
GSM1303941PDAC Late Ablation_anti-CTLA4 222.346
GSM1303942PDAC Late Ablation_anti-CTLA4 312.926